Annual report [Section 13 and 15(d), not S-K Item 405]

Note 14 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.25.0.1
Note 14 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Depreciation and other $ 119 $ 136
Net operating loss carryforwards 54,001 52,448
Research and development tax credits 2,210 2,219
Accruals and reserves 235 311
Capitalized research and development costs 1,817 1,422
Deferred revenue 400 220
Stock compensation expense 1,028 1,493
Lease assets 154 178
Other 48 50
Lease liabilities (133) (152)
Prepaid expenses (54) (56)
Less: Valuation allowance (59,825) (58,269)
Net deferred tax asset (liability) $ 0 $ 0